LRI Validation Suite WG Update for LRI Pilot WG May 1, 2012.

Slides:



Advertisements
Similar presentations
Reflex, Confirmatory and Add-on Testing
Advertisements

LRI Validation Suite Meeting August 16, Agenda Review of LRI Validation Suite Charter/Overview Acquiring test data update Review of proposed test.
LRI/LOI Pilots May 1, Participants Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis Support Team Others.
S&I Framework Testing HL7 V2 Lab Results Interface and RI Pilot Robert Snelick National Institute of Standards and Technology June 23 rd, 2011 Contact:
Cardinality Behaviors Discussion November 13, 2013 Version 4.0.
Training Program Version 3.06 Use Page-up and Page-down to scroll through the slide show EZ-Cup Drug Screen The EZ-Cup Drug Screen is only a preliminary.
All You Would Ever Want to Know about Urine Toxicology Screening Mohammad Al-Ghoul, PhD Chief Technical Officer Diane A. Tennies, PhD Lead TEAP Health.
Result Status Relationships
1 Cardinality Specification and Testing Recommendations LOI and LRI MU Certification September 9 th, 2013 Draft
1 Work Plan for Testing the LIS and EHR Systems Define Test Flow based from Work Flow Define a testing methodology Develop high-level requirements for.
CVD Risk Reduction Group Retention Draft Guidelines July 2005.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting January 23, 2012.
LRI Validation Suite Meeting November 1st, Agenda Review of LIS Test Plan Template CLIA Testing EHR testing (Juror Document)—Inspection Testing.
LRI Validation Suite Meeting November 15th, 2011.
LRI Validation Suite LRI Validation Suite Meeting Rob Snelick—NIST April 24th, 2012.
Microscopic Sediment – Epithelial Cells
LRI Validation Suite LRI Validation Suite Meeting Rob Snelick—NIST March 27th, 2012.
MHD II Laboratory Session Cytology APRIL 24, 2014.
Clinical Oral Presentation Jessica Ward.  “I committed myself to the proactive stance of health promotion and disease prevention with the conviction.
LRI Validation Suite Meeting November 8th, Agenda Review of LIS Test Plan Template – Follow-up; Questions Review of EHR Test Plan – EHR Pre-test.
LRI Validation Suite LRI Prototype Tool Demonstration Rob Snelick—NIST January 31st, 2011.
Laboratory Pilots/Deployment May 15, Participants Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis Support.
3SAQS Technical Committee Workshop Overview of updated schedule / deliverables related to ongoing 3SAQS technical work October 31, 2013 Tom Moore.
LRI Validation Suite Meeting September 20, Agenda Action Item List Test data update – Selection of core message set – NIST data sets and management.
LRI Validation Suite Meeting October 11th, Agenda (Red=topics today) Action Item List Test data update – Selection of core message set – Review.
LRI Validation Suite Meeting September 06, Agenda Test data update – Selection of core message set Update Review validation discussion page – Mapping.
MTN-027 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
بسم الله الرحمن الرحيم.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting March 12, 2012.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 15, 2011.
LRI Validation Suite Meeting October 4th, Agenda Action Item List Test data update – Selection of core message set – Review of lab results test.
EHR-S Functional Requirements IG: Lab Results Interface 10/17/2014.
Anatomic Pathology Reporting Challenge Reporting methods over HL7 transactions vary significantly by vendor –Result Segment(s) -- OBXs –Note Segment(s)
LRI Validation Suite Meeting September 27, Agenda Action Item List Test data update – Selection of core message set – Review of lab results test.
The beneficiary register in the Participant Portal Suggestions for improving the user experience 27 May 2015.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 1, 2011.
Grading And Staging Grading is based on the microscopic features of the cells which compose a tumor and is specific for the tumor type. Staging is based.
Lab Results Interface Validation Suite WG July 28, 2011.
Lab Reporting Interface – Implementation Guide Analysis- Kick-off Bob Yencha, Erik Pupo April 6,
1.
LRI Validation Suite Meeting Prototype Tool Demonstration December 20th, 2011.
Information Exchange Workgroup June 14, IE WG Presentation to HITPC (draft) IE WG Workplan Query exchange recommendations Provider directory.
LOINC (UNIVERSAL) ORDER CODES SINGLE TEST LIST Quest Diagnostics Review July 2014.
Laboratory Pilots/Deployment June 26, Participants Coordination of Effort Validation Suite Vocabulary Group Implementation Guide Analysis LRI/LOI/eDOS.
20/11/2009 DICOM WG13 Atsushi Amano Medical Imaging Systems Committee Japanese Association of Healthcare Information Systems Industry (JAHIS) 1 JAHIS /
SAFER Action Plan Overview. Action Plan Components Enforcement operations (including tools Enforcement operations (including tools that focus on party.
Updates on State Assessments Steven Katz Director Office of State Assessment.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting August 29, 2011.
MTN-028 Laboratory Related CRFs. Pharmacokinetics Specimens (PKS-1) - Enrollment, Day 28 Pharmacokinetics Specimens (PKD-1) - Days 1, 2, 3, 7, 14, 21,
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting February 13, 2012.
Lab Results Interface Validation Suite Workgroup and Pilots Workgroup Vision, Charter, NIST Collaboration, July 8,
GZR/EBR 100/50 mg qd N = 201 N = 100 W12W24 W16 PlaceboGZR/EBR W28 > 18 years HCV infection Genotype 1, 4, 6 Treatment-naïve ≥ 3 months opioid replacement.
Lab Results Interface Pilots WG Kick-Off August 1, 2011.
Pathology & Laboratory By Alejandra Munoz, CPC, NCICS.
Electronic Pathology Reports and the Use of HL7 Messaging Workbench 2008 NAACCR Conference Ken Gerlach, MPH, CTR CDC-National Program of Cancer Registries.
Statistical Considerations for Detection of Bladder Cancer by Microsatellite Analysis (MSA) of Urinary Sediment: Multi-Institutional Study Presentation.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting November 21, 2011.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting September 12, 2011.
Lab Results Interfaces S&I Framework Initiative Bi-Weekly Initiative Meeting July 18, 2011.
Microbiology Discrete Results Reporting Presenters: Tymn Neece Sonal Pandey Lancaster General Hospital Lancaster, Pa.
Cervical cancer screening and treatment among HIV+ women in Cambodia: feasible and high yielding M.-E. Raguenaud 1, P. Isaakidis 1, S.A. Khim 1, C. Ping.
Medical Diagnostic Center- L.E.M
S S S - Figure 2: Guidelines for primary HPV screening in South Africa
Roles and Responsibilities (1/3)
Updates on State Assessments
The Mighty Filter Introducing Filter Node Filtering config settings
CPT Pathology and Laboratory
Figure 1: Guidelines for primary cytology# screening in South Africa
Diagnostic Tools.
Presentation transcript:

LRI Validation Suite WG Update for LRI Pilot WG May 1, 2012

Phase 1 Core Test Messages Profile Type Short DescriptionMessage Type NG Minimally Populated SED Rate message - Final Results Minimum GU Minimally Populated SED Rate message - Final Results Minimum NG Typically Populated SED Rate message - Final Results Typical-Final GU Typically Populated SED Rate message - Final Results Typical-Final NG Typically Populated SED Rate message - Corrected Results Typical-Corrected GU Typically Populated SED Rate message - Corrected Results Typical-Corrected NG Maximally Populated SED Rate message - Final Results Maximum GU Maximally Populated SED Rate message - Final Results Maximum NG Rejected SED Rate Message (No OBX segment; OBR.25 = X) Specimen Reject GU Rejected SED Rate Message (No OBX segment; OBR.25 = X) Specimen Reject NG Typically Populated CBC message - Final Results Typical GU Typically Populated CBC message - Final Results Typical NG Typically Populated Lipid Panel message - Final Results Typical GU Typically Populated Lipid Panel message - Final Results Typical NG Culture-Campylobacter jejuni, Salmonella, Shigella - Parent - Preliminary NG-Parent-Linking GU Culture-Campylobacter jejuni, Salmonella, Shigella - Parent - Preliminary GU-Parent-Linking NG-RU Culture-Campylobacter jejuni, Salmonella, Shigella - Parent/Child Susceptibility - Final NG-RU-Parent-Child-Linking GU-RU Culture-Campylobacter jejuni, Salmonella, Shigella - Parent/Child Susceptibility - Final GU-RU-Parent-Child-Linking NG-RN Culture-Campylobacter jejuni, Salmonella, Shigella - Parent/Child Susceptibility - Final NG-RN-Parent-Child-Linking GU-RN Culture-Campylobacter jejuni, Salmonella, Shigella - Parent/Child Susceptibility - Final GU-RN-Parent-Child-Linking

Phase 2 Test Messages* Anatomical Pathology/Surgical Pathology Study – Example of A4 result – Two draft messages completed (Skin biopsy and Inguinal Lymph Node biopsy) HIV 1 Ab [Presence] – Example of Reflex testing – Draft message completed A toxicology test – Example of Screening followed by Reflex testing – Draft Screening message for Amphetamines [Presence] in Urine with negative result completed; Reflex draft message needed – Other test messages could include urine test for Cannabinoids, Cocaine, Opiates, Phencyclidine *Will start including in Validation Tool and Test Plans in June 2012

Phase 2 Test Messages (cont’d) Cytology Panel with four components – Example of combination of A2 and A4 results in a panel Specimen source (identifier) in cervical or vaginal smear or scraping by Cyto stain – example of A2 result Cytology report of cervical or vaginal smear or scraping Cyto stain thin prep – example of A4 result Recommended follow-up (identifier) in cervical or vaginal smear or scraping by Cyto stain – example of A2 result Cytology study comment on cervical or vaginal smear or scraping by Cyto stain – example of A4 result – Draft message needed

Phase 2 Test Messages (cont’d) Human Genome – CFTR gene mutations found [Identifier] – Example of A3 result – Draft message completed Complete Urinalysis (panel test) – lowest priority test – Example of A2 result Draft message completed - to be modified using “+” or “++ “for bilirubin result value – Example of A4 results Urine sediment comments

Needed from Pilots Testers and feedback for current version of Validation Suite tool Volunteers for 1-on-1 Webex testing – Especially EHR systems – Validation Suite to be ready in June 2012